Molina Healthcare, Inc. Q2 2025 Earnings Recap

Molina Healthcare reported Q2 2025 adjusted earnings per share of $5.48, with premium revenue at $10.9 billion, amidst continuing medical cost pressures reflected in an elevated medical care ratio (MCR) of 90.4%.

Key Takeaways

• The consolidated MCR for the quarter reached 90.4%, attributed to unprecedented medical cost trends, particularly in behavioral health and high-cost pharmaceuticals.
• Full year 2025 adjusted EPS guidance revised down to a floor of $19, a significant reduction from previous expectations, largely driven by marketplace dynamics.
• Medicaid MCR of 91.3% exceeds long-term targets, while Medicare and Marketplace MCRs also reflect increased utilization pressures.
• The company maintains a conservative outlook, emphasizing potential for earnings upside if cost trends moderate in the second half of the year.